John A. Stalfort III - 06 Jun 2023 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Derek Meisner, Attorney-in-Fact
Issuer symbol
ABOS
Transactions as of
06 Jun 2023
Transactions value $
$0
Form type
4
Filing time
07 Jun 2023, 17:45:31 UTC
Previous filing
05 Jul 2022
Next filing
26 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABOS Stock Option (right to buy) Award $0 +25K $0.00 25K 06 Jun 2023 Common Stock 25K $5.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 6, 2024 or the 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney